179 related articles for article (PubMed ID: 28994557)
1. Increasing survival of metastatic breast cancer through locoregional surgery.
Díaz de la Noval B; Frías Aldeguer L; Ángeles Leal García M; García López E; Díaz Almirón M; Herrera de la Muela M
Minerva Ginecol; 2018 Feb; 70(1):44-52. PubMed ID: 28994557
[TBL] [Abstract][Full Text] [Related]
2. Locoregional surgical treatment improves the prognosis in primary metastatic breast cancer patients with a single distant metastasis except for brain metastasis.
Li X; Huang R; Ma L; Liu S; Zong X
Breast; 2019 Jun; 45():104-112. PubMed ID: 30928762
[TBL] [Abstract][Full Text] [Related]
3. Surgery of primary tumour has survival benefit in metastatic breast cancer with single-organ metastasis, especially bone.
Rhu J; Lee SK; Kil WH; Lee JE; Nam SJ
ANZ J Surg; 2015 Apr; 85(4):240-4. PubMed ID: 25996008
[TBL] [Abstract][Full Text] [Related]
4. [Local recurrence based on size after conservative surgery in breast cancer stage T1-T2. A population-based study].
Martínez-Ramos D; Fortea-Sanchis C; Escrig-Sos J; Prats-de Puig M; Queralt-Martín R; Salvador-Sanchis JL
Cir Cir; 2014; 82(3):252-61. PubMed ID: 25238466
[TBL] [Abstract][Full Text] [Related]
5. Impact of locoregional treatment on survival in patients presented with metastatic breast carcinoma.
Gultekin M; Yazici O; Eren G; Yuce D; Aksoy S; Ozisik Y; Guler N; Yazici G; Hurmuz P; Yildiz F; Altundag K; Gurkaynak M
Breast; 2014 Dec; 23(6):775-83. PubMed ID: 25201554
[TBL] [Abstract][Full Text] [Related]
6. Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer.
Cao L; Ou D; Shen KW; Cai G; Cai R; Xu F; Zhao SG; Xu C; Grellier Adedjouma N; Kirova YM; Chen JY
Cancer Radiother; 2018 Feb; 22(1):38-44. PubMed ID: 29306555
[TBL] [Abstract][Full Text] [Related]
7. Local-regional radiotherapy and surgery is associated with a significant survival advantage in metastatic breast cancer patients.
Ly BH; Vlastos G; Rapiti E; Vinh-Hung V; Nguyen NP
Tumori; 2010; 96(6):947-54. PubMed ID: 21388057
[TBL] [Abstract][Full Text] [Related]
8. Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis.
Pons-Tostivint E; Kirova Y; Lusque A; Campone M; Geffrelot J; Mazouni C; Mailliez A; Pasquier D; Madranges N; Firmin N; Crouzet A; Gonçalves A; Jankowski C; De La Motte Rouge T; Pouget N; de La Lande B; Mouttet-Boizat D; Ferrero JM; Uwer L; Eymard JC; Mouret-Reynier MA; Petit T; Robain M; Filleron T; Cailliot C; Dalenc F
Ann Surg Oncol; 2019 Feb; 26(2):356-365. PubMed ID: 30539492
[TBL] [Abstract][Full Text] [Related]
9. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
[TBL] [Abstract][Full Text] [Related]
10. Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients.
Omarini C; Guaitoli G; Noventa S; Andreotti A; Gambini A; Palma E; Papi S; Tazzioli G; Balduzzi S; Dominici M; Cascinu S; Piacentini F
Eur J Surg Oncol; 2017 Apr; 43(4):613-618. PubMed ID: 27793416
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
Lobbezoo DJ; van Kampen RJ; Voogd AC; Dercksen MW; van den Berkmortel F; Smilde TJ; van de Wouw AJ; Peters FP; van Riel JM; Peters NA; de Boer M; Peer PG; Tjan-Heijnen VC
Br J Cancer; 2015 Apr; 112(9):1445-51. PubMed ID: 25880008
[TBL] [Abstract][Full Text] [Related]
12. Can locoregional treatment of the primary tumor improve outcomes for women with stage IV breast cancer at diagnosis?
Nguyen DH; Truong PT; Alexander C; Walter CV; Hayashi E; Christie J; Lesperance M
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):39-45. PubMed ID: 22330986
[TBL] [Abstract][Full Text] [Related]
13. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?
Weissenbacher TM; Zschage M; Janni W; Jeschke U; Dimpfl T; Mayr D; Rack B; Schindlbeck C; Friese K; Dian D
Breast Cancer Res Treat; 2010 Jul; 122(1):27-34. PubMed ID: 20454925
[TBL] [Abstract][Full Text] [Related]
14. "Clinical significance of multifocal and multicentric breast cancers and choice of surgical treatment: a retrospective study on a series of 1158 cases".
Neri A; Marrelli D; Megha T; Bettarini F; Tacchini D; De Franco L; Roviello F
BMC Surg; 2015 Jan; 15(1):1. PubMed ID: 25586679
[TBL] [Abstract][Full Text] [Related]
15. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
Mamtani A; Patil S; Stempel MM; Morrow M
Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423
[TBL] [Abstract][Full Text] [Related]
16. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy.
Truong PT; Yong CM; Abnousi F; Lee J; Kader HA; Hayashi A; Olivotto IA
J Am Coll Surg; 2005 Jun; 200(6):912-21. PubMed ID: 15922205
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Modeling in Pathologic N1 Breast Cancer Without Elective Nodal Irradiation After Current Standard Systemic Management.
Yu JI; Park W; Choi DH; Huh SJ; Nam SJ; Kim SW; Lee JE; Kil WH; Im YH; Ahn JS; Park YH; Cho EY
Clin Breast Cancer; 2015 Aug; 15(4):e197-204. PubMed ID: 25957739
[TBL] [Abstract][Full Text] [Related]
18. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery.
Gosset M; Hamy AS; Mallon P; Delomenie M; Mouttet D; Pierga JY; Lae M; Fourquet A; Rouzier R; Reyal F; Feron JG
PLoS One; 2016; 11(8):e0159888. PubMed ID: 27494111
[TBL] [Abstract][Full Text] [Related]
20. Early Locoregional Breast Surgery and Survival in de novo Metastatic Breast Cancer in the Multicenter National ESME Cohort.
Hotton J; Lusque A; Leufflen L; Campone M; Levy C; Honart JF; Mailliez A; Debled M; Gutowski M; Leheurteur M; Goncalves A; Jankowski C; Guillermet S; Bachelot T; Ferrero JM; Eymard JC; Petit T; Pouget N; de La Lande B; Frenel JS; Villacroux O; Simon G; Pons-Tostivint E; Marchai F
Ann Surg; 2023 Jan; 277(1):e153-e161. PubMed ID: 33534229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
